Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Over $10B invested in last 18 months! Download free report on life science investment in China.
ChinaBio® Leadership Retreat Brings 120 Senior Life Science Executives Together to “Rethink China”
“ChinaBio’s second Leadership Retreat brought together an amazing group of industry leaders with deep experience and important insights who can truly affect change in China,” said Greg Scott, Founder and CEO of ChinaBio®. “This year’s discussions focused on how the industry is rapidly changing globally as well as in China, and how both multinational and domestic companies need to change their strategies to be successful in China.”
To set the stage for later discussions, John Cai, PhD, Director of the Center for Health Care Management and Policy and Adjunct Professor of Economics at China Europe International Business School (CEIBS), delivered the keynote address. During his twenty-year career, Dr. Cai has focused on the intersection of health care economics and health care policy in both the U.S. and China. He participated in the design and implementation of the first comprehensive health care reform plan in the U.S. (Massachusetts) and was actively involved in the design of China’s National Health Care Reform Program, which committed $125 billion in 2009 to improve the quality and delivery of health care.
Other speakers featured in the morning sessions included Dr. Karen Bernstein, Co-founder and Chairman of BioCentury Publications, and Dr. Jason Mann, Head, China Healthcare Equity Research at Barclays Capital.
The afternoon consisted of interactive working sessions designed to develop actionable “lessons learned” that delegates could use to build their business strategies for China in 2013 and beyond.
“It was great to see some very creative ideas being shared frankly with the group, and I’m happy ChinaBio could be part of that,” Scott added.
The second day was dedicated to networking at the East Sea Golf & Country Club in Taicang. Delegates were offered the chance to play a round of golf on this 18-hole championship course designed by Colin Montgomerie. After golf, delegates attended a closing reception at the country club, where they met for a final time to discuss the results of the Retreat’s activities and plan the next steps for collaboration.
About ChinaBio® LLC
ChinaBio® LLC is a consulting and advisory firm based in Shanghai and San Diego that has created a broad platform of capabilities connecting China life science with the world. ChinaBio has helped global life science companies identify over 400 licensing and acquisition opportunities in China and China companies raise over $500 million in funding.
• Consulting: ChinaBio works with global life science companies and China executives to define and execute a successful global strategy.
• Capital: ChinaBio helps companies secure partnerships and acquisitions and access private and government funding in China.
• Conferences: ChinaBio organizes the premier life science investment and partnering conferences in China, having attracted nearly 5,000 attendees.
• Publishing: ChinaBio® Today is the most widely read online and email newsletter on China’s life science industry, with nearly 20,000 readers.
More information is available at www.chinabiollc.com.
Taicang is the nearest satellite city to Shanghai, only 35 minutes from Hongqiao International Airport and 45 minutes to Shanghai downtown by car. Taicang New Development Zone had established a new life science park which has attracted over 60 life science companies including Cyagen, CrownBio and Joinn Laboratories, which has built a nearly 700,000 sq. ft. facility in the park.
More information is available at www.taicang.gov.cn.